12 резултати
BACKGROUND OF THE PRESENT INVENTION
1. Field of Invention
The present invention relates to ursolic acid medicine, and more particularly, relates to freeze-dried ursolic acid nano-powder for injection as the preparation method thereof.
2. Description of Related Arts
Ursolic acid is a kind of organic
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
BACKGROUND
Small-molecule inhibitors of various classes of kinases have become significant exploratory medicinal compounds. However, certain kinase inhibitors possess properties of low water solubility and poor oral bioavailability.
Among the various classes of kinases for which experimental